Global AI Endoscopy Software Market Strategic Research Report

Scope of the Report

The global AI Endoscopy Software market size is predicted to grow from US$ 838 million in 2025 to US$ 1,558 million in 2032; it is expected to grow at a CAGR of 9.4% from 2026 to 2032.

Artificial intelligence endoscopy software is an auxiliary tool that combines AI technologies such as deep learning with medical endoscopic examinations. In endoscopic diagnosis and treatment scenarios such as the digestive and respiratory tracts, it automatically identifies and marks the location of lesions such as polyps and early-stage cancers by analyzing real-time images. It can also assist in judging the nature of lesions, assessing the quality of the operation, and providing doctors with a "second opinion." At its core, it uses an algorithm model trained on massive amounts of medical images to improve the lesion detection rate, reduce missed diagnoses, and reduce the workload of doctors. In particular, it helps primary hospitals standardize diagnosis and treatment procedures, making early disease screening more accurate and efficient, and securing the best treatment opportunity for patients.

The upstream of the AI endoscopy software industry chain mainly includes medical imaging data sources, GPU/AI acceleration chips, deep learning frameworks, annotation platforms, and hospital imaging system interfaces. Data sources are provided by large hospitals and multi-center clinical databases, serving as the core resource for algorithm training. Chips and computing power are primarily provided by NVIDIA, Intel, and domestic AI inference chip suppliers. Algorithm training relies on frameworks such as TensorFlow and PyTorch. Imaging interfaces come from hospital HIS/PACS/endoscopy system manufacturers. Downstream applications are mainly concentrated in the gastroenterology, endoscopy, respiratory, and general surgery departments of general hospitals. Gastroenterology endoscopy has the strongest demand due to the huge annual volume of gastrointestinal endoscopy examinations and the high risk of missed early cancers and polyps. AI software can provide real-time lesion identification, quality control, and lesion annotation suggestions, significantly reducing experience-based discrepancies, making it the scenario hospitals are most willing to pay for. In respiratory medicine, AI for bronchoscopy is used for lesion localization and navigation, but its commercial value is relatively limited due to the small number of cases. In general surgery, it is mainly used for anatomical structure identification and risk structure alerts during laparoscopic surgery; its adoption is constrained by strict regulatory requirements and doctors' high demands for algorithm reliability. Health checkup centers and chain endoscopy centers, with their strong demand for standardized processes, have become a rapidly growing downstream customer group. AI can improve the homogeneity of examinations, reduce human error, and increase efficiency.

The industry's development trend shows a shift from single lesion identification to comprehensive multi-disease identification, and from real-time assistance to intelligent quality control and surgical decision support. Simultaneously, software is gradually decoupling from hardware platforms, achieving cross-brand compatibility with endoscopy equipment. Driving factors include rising demand for gastrointestinal cancer screening, hospitals' strong desire to reduce missed diagnoses, enhanced real-time inference capabilities brought about by mature AI technology, increasingly clear regulatory definitions of AI medical software categories, and the advancement of hospital digitalization. Obstacles include the difficulty in obtaining high-quality labeled data, significant differences in algorithm generalization capabilities across different hospitals, complex compatibility between hospital networks and endoscopy systems, varying levels of psychological acceptance among doctors regarding AI reliance, long regulatory approval cycles affecting the speed of commercialization, and high product prices limiting adoption in primary care hospitals.

The software product team can complete approximately 300–800 hospital-side deployments annually, with a gross profit margin of 70%–85%.

This report presents a comprehensive overview of the global AI Endoscopy Software market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• CADe (Computer-Aided Detection)
• CADx (Computer-Aided Diagnosis)

Segment by Deployment Methods

• Edge AI
• Cloud AI Analysis Platform
• Standalone AI Box

Segment by Output Format

• Real-time Assistance
• Post-event Image Review
• Quality Control Report

Segment by Application

• Gastroenterology
• Pulmonary Medicine
• Urology
• Otolaryngology (ENT)
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global AI Endoscopy Software market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Gastroenterology, Pulmonary Medicine, Urology evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact